Company Filing History:
Years Active: 2011
Title: Innovations of Warren Howard in Sequence Selective Compounds
Introduction
Warren Howard is an accomplished inventor based in Mt. Annan, Australia. He has made significant contributions to the field of biochemistry, particularly in the development of sequence selective compounds. His work focuses on targeting therapeutic and diagnostic groups to polynucleotides, which has important implications for medical research and treatment.
Latest Patents
Warren Howard holds a patent for "Sequence selective pyrrole and imidazole polyamide metallocomplexes." This invention relates to sequence selective compounds that facilitate the targeting of therapeutic or diagnostic groups to polynucleotides. More specifically, it addresses the sequence selective targeting of metallocomplexes, such as metallodrugs and metallodiagnostics, to polynucleotides.
Career Highlights
Warren Howard is affiliated with the University of Western Sydney, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in the medical field, particularly in enhancing the effectiveness of treatments through targeted delivery systems.
Collaborations
Warren has collaborated with notable colleagues, including David Jaramillo and Craig Brodie. These partnerships have contributed to the development and refinement of his innovative ideas and patents.
Conclusion
Warren Howard's contributions to the field of sequence selective compounds demonstrate his commitment to advancing medical research. His patent on metallocomplexes highlights the potential for targeted therapies that could revolutionize treatment methodologies.